
If you are between the ages of 8-30
and have been recently diagnosed with Type 1 Diabetes,
you may be eligible to participate.
Click here to begin learning more about the AbATE Trial.

 
The AbATE trial is being conducted by the Immune Tolerance Network.
It is sponsored by the National Institute of Allergy & Infectious Diseases,
with support from the Juvenile Diabetes Research Foundation.
|